Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atherosclerosis Obliterans”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Testing effectiveness (Phase 2)Study completedNCT02501018
What this trial is testing

Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI)

Who this might be right for
Critical Limb IschemiaBuerger DiseaseThromboangiitis Obliterans+1 more
Lisata Therapeutics, Inc. 33
Not applicableEnrolling By InvitationNCT07023965
What this trial is testing

Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)

Who this might be right for
Peripheral Arterial Disease(PAD)Arterial Occlusive DiseaseArteriosclerosis Obliterans+4 more
Beijing Northland Biotech. Co., Ltd. 542
Post-approval studies (Phase 4)Study completedNCT00823849
What this trial is testing

Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker

Who this might be right for
Type 2 Diabetes MellitusArteriosclerosis Obliterans
Otsuka Beijing Research Institute 200
Not applicableStudy completedNCT01518205
What this trial is testing

HELP-Apheresis in Diabetic Ischemic Foot Treatment (H.A.D.I.F)

Who this might be right for
Foot UlcersArteriosclerosis ObliteransDiabetes Mellitus
Universita di Verona 13
Testing effectiveness (Phase 2)Study completedNCT01484574
What this trial is testing

A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease

Who this might be right for
Critical Limb IschemiaBuerger's Disease
Stempeutics Research Pvt Ltd 90
Testing effectiveness (Phase 2)UnknownNCT01446055
What this trial is testing

Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia

Who this might be right for
Critical Limb IschemiaPeripheral Arterial DiseaseBuerger's Disease
Xuanwu Hospital, Beijing 50
Not applicableUnknownNCT04440072
What this trial is testing

Comparison of 3 Ultrasonic Techniques for Measuring the Systolic Pressure Index

Who this might be right for
Peripheral Arterial DiseaseAtherosclerosis ObliteransAtherosclerosis Right Leg+1 more
University Hospital, Caen 150
Not applicableActive Not RecruitingNCT06724276
What this trial is testing

Combined Treatment for Non-Healing Wounds in Chronic Lower Extremity Arterial Disease: a Comparative Study

Who this might be right for
Obliterans, ArteriosclerosisPeripheral Arterial DiseaseDiabetic Foot
Tulip Medicine 116
Not applicableStudy completedNCT03020290
What this trial is testing

Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents

Who this might be right for
Atherosclerosis Obliterans
Nantes University Hospital 335
Not applicableStudy completedNCT03013088
What this trial is testing

Soundbite Crossing System Peripheral First in Man

Who this might be right for
Peripheral Artery Disease
SoundBite Medical Solutions, Inc. 37
Testing effectiveness (Phase 2)UnknownNCT02864654
What this trial is testing

Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia

Who this might be right for
Critical Limb IschemiaArteriosclerosis ObliteransPeripheral Arterial Disease+2 more
Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation 9
Post-approval studies (Phase 4)Looking for participantsNCT05854615
What this trial is testing

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease

Who this might be right for
Critical Limb IschemiaBuerger's Disease
Cell Biopeutics Resources Sdn Bhd 3
Testing effectiveness (Phase 2)Study completedNCT01595776
What this trial is testing

Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia

Who this might be right for
Critical Limb Ischemia
Fondazione IRCCS Policlinico San Matteo di Pavia 8
Not applicableUnknownNCT01233141
What this trial is testing

Viennese Registry on Patients With Chronic Critical Limb Ischemia

Who this might be right for
Chronic (> 2 Weeks) Critical Ischemia With Skin Defect in Lower Limbs
Medical University of Vienna 400
Not applicableUnknownNCT02089828
What this trial is testing

Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia

Who this might be right for
Thromboangiitis ObliteransArteritisPeripheral Arterial Disease
Shanghai Zhongshan Hospital 50
Not applicableUnknownNCT04746599
What this trial is testing

Autologous Fat Grafting in the Treatment of Critical Limb Ischaemia

Who this might be right for
Critical Limb IschemiaPeripheral Arterial Disease - PADIschemic Ulcer+5 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 20
Not applicableUnknownNCT00145262
What this trial is testing

TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation

Who this might be right for
Buerger DiseaseArteriosclerosis Obliterans
Nagoya University
Not applicableUnknownNCT05473884
What this trial is testing

Lesion Preparation in Femoropopliteal Artery Occlusion Disease

Who this might be right for
Femoropopliteal Artery OcclusionAtherosclerosis ObliteransLesion; Vascular+1 more
Shanghai Pudong Hospital 800